메뉴 건너뛰기




Volumn 286, Issue 51, 2011, Pages 44045-44056

The antifungal drug itraconazole inhibits Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANTI-ANGIOGENIC ACTIVITY; ANTIFUNGAL DRUGS; CELL SURFACE EXPRESSION; CELLULAR CHOLESTEROL; CHOLESTEROL ACCUMULATION; CLINICAL TRIAL; EPIDERMAL GROWTH FACTOR RECEPTORS; GROWTH FACTOR; ITRACONAZOLE; MAMMALIAN TARGET OF RAPAMYCIN (MTOR); N-GLYCANS; PHOSPHOLIPASE C; RENAL CELL CARCINOMA; SMALL MOLECULES; TUMOR GROWTH; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR-2;

EID: 83755162608     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.278754     Document Type: Article
Times cited : (107)

References (46)
  • 6
    • 79551559952 scopus 로고    scopus 로고
    • Hayes, D. F. (2011) JAMA 305, 506-508
    • (2011) JAMA , vol.305 , pp. 506-508
    • Hayes, D.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.